Y-4-LC-02 (US) Phase 1 Study
Frontage Clinical Services prioritizes the safety and well-being of our study participants, our employees, and visitors to our clinic. As such, we have incorporated additional policies and procedures, as recommended by the CDC.
Participate in a Phase I Clinical Trial
Phase 1 study designed to compare how a new investigational medication (Y-4) behaves in the body versus its individual components, pregabalin and riluzole, when taken on an empty stomach. The study will also assess the safety and tolerability of these medications in healthy adults. Compensation up to $9,050 for your time and participation.
To participate, you must:
- Be a Healthy Adult
- Be 18 to 45 years old
- Have a BMI between 19 to 28 kg/m2
- Be a Non-Smokers, Non-Vapers and not used other Tabacco Products
- Have a Good Venous Access
Study Requirements:
- Period 1 (Days 1–4): Y-4 tablet (combination of pregabalin and riluzole) with monitoring for 3 days
- Period 2 (Days 8–11): Pregabalin capsule with monitoring for 3 days
- Period 3 (Days 15–18): Riluzole tablet with monitoring for 3 days
- Discharge on Day 18 followed by 1 follow-up phone call about 7 days later